Convalescent Plasma to Treat COVID-19: A Two-Center, Randomized, Double-Blind Clinical Trial

Background: The use of convalescent plasma (CP) has been considered for its immunological mechanisms that could benefit patients in moderate and severe stages of COVID-19. This study evaluated the safety and efficacy of the use of donor CP for COVID-19. Material and methods: A double-blind, randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Ventura-Enríquez, Yanet, Cabello-Gutiérrez, Carlos, Pérez-Calatayud, Ángel Augusto, Cortina-De la Rosa, Evelyn, Fareli-González, Christian Javier, Castillo-Juárez, Paola, Carlos, Alberto Peña-Pérez, Zavaleta-Martínez, Elí Omar, Diaz-Padilla, Elizabeth, Murrieta, Sandra, Álvarez-Jiménez, Violeta Deyanira, Ponce-Medrano, Juan Alberto Díaz, Casillas-Suárez, Catalina, Ocampo-Ocampo, María Angelica, Vargas-De-León, Cruz, Fernández-Sánchez, Verónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692718/
https://www.ncbi.nlm.nih.gov/pubmed/36362922
http://dx.doi.org/10.3390/life12111767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692718/
https://www.ncbi.nlm.nih.gov/pubmed/36362922
http://dx.doi.org/10.3390/life12111767

Ejemplares similares